For dealing with epilepsy, marijuana represents one of the most promising uses of medicinal marijuana. Most often, this concept is used to justify recreational marijuana. Importantly, the two main components of marijuana, specifically CBD and THC, have been shown to have differential effects. Overall, its appeal has been gaining steam or interest in the medical community. In June 2018, the FDA approved Epidiolex for the treatment of seizures associated with epilepsy, specifically Lennox-Gastaut syndrome and Dravet syndrome. This site does not support or condone this specific medication, but rather this information is presented strictly for educational purposes only. This site seeks to provide the reader with updates on the research examining the potential use of marijuana to treat symptoms associated with epilepsy.
Perucca, E. (2017). Cannabinoids in the treatment of epilepsy: Hard evidence at last? Journal of Epilepsy Research, 7(2), 61-76. https://doi.org/10.14581/jer.17012
Kerr, A., Walston, V., Wong, V. S. S., Kellog, M., & Ernst, L. (2019). Marijuana use among patients with epilepsy at a tertiary care center. Epilepsy & Behavior, 97, 144-148. https://doi.org/10.1016/j.yebeh.2019.05.037
Detyniecki, K., & Hirsch, L. J. (2015). Marijuana use in epilepsy: The myth and the reality. Current Neurology and Neuroscience Reports, 15(10), 1-6. https://doi.org/10.1007/s11910-015-0586-5
Copyright © 2023 Marijuana Scholar - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.